| General Information of Drug Metabolite (DM) (ID: DM017845) |
| DM Name |
Almokalant Metabolite M18
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
UDP-glucuronyltransferase (UGT)
|
DMEN064
|
| Unclear - Unclear |
Almokalant
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Almokalant |
DR3071
|
Discontinued in Phase 3 |
Cardiac arrhythmias |
|
|
| References |
| 1 |
An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalant
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
